ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.628,58
-0,30%
S&P 500
5.306,04
0,02%
Dow Jones
38.852,86
-0,55%
Euro vs US Dollar
1,08581
0,04%
Bitcoin
68.121,53
-0,25%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Profound Medical Corporation (PROF)

  7. Profound Medical Corporation (PROF) News

PROF

Profound Medical (PROF)

Profound Medical Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PROF
DatumZeitQuelleÜberschriftSymbolFirma
15/05/202423h00GlobeNewswire Inc.Profound Medical Annual General Meeting of Shareholders Voting ResultsNASDAQ:PROFProfound Medical Corporation
15/05/202422h12PR Newswire (Canada)PROFOUND MEDICAL ANNUAL GENERAL MEETING OF SHAREHOLDERS VOTING RESULTSNASDAQ:PROFProfound Medical Corporation
14/05/202415h30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PROFProfound Medical Corporation
14/05/202413h30GlobeNewswire Inc.Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment PlanNASDAQ:PROFProfound Medical Corporation
09/05/202422h15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PROFProfound Medical Corporation
09/05/202422h05GlobeNewswire Inc.Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue GuidanceNASDAQ:PROFProfound Medical Corporation
06/05/202422h30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PROFProfound Medical Corporation
06/05/202422h15GlobeNewswire Inc.Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease SpectrumNASDAQ:PROFProfound Medical Corporation
22/04/202422h15GlobeNewswire Inc.Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to FollowNASDAQ:PROFProfound Medical Corporation
09/04/202413h45GlobeNewswire Inc.Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor ConferenceNASDAQ:PROFProfound Medical Corporation
07/03/202422h05GlobeNewswire Inc.Profound Medical Announces Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PROFProfound Medical Corporation
04/03/202422h30GlobeNewswire Inc.Profound Medical to Participate in Barclays 26th Annual Global Healthcare ConferenceNASDAQ:PROFProfound Medical Corporation
27/02/202413h45GlobeNewswire Inc.Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA ProcedureNASDAQ:PROFProfound Medical Corporation
15/02/202422h30GlobeNewswire Inc.Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to FollowNASDAQ:PROFProfound Medical Corporation
16/01/202422h30GlobeNewswire Inc.Profound Medical Announces Non-Brokered Private PlacementNASDAQ:PROFProfound Medical Corporation
03/01/202422h15GlobeNewswire Inc.Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 RevenuesNASDAQ:PROFProfound Medical Corporation
28/12/202304h40GlobeNewswire Inc.Profound Medical Announces Pricing of US$20 Million Public Offering of Common SharesNASDAQ:PROFProfound Medical Corporation
27/12/202322h15GlobeNewswire Inc.Profound Medical Announces Proposed Public Offering of Common SharesNASDAQ:PROFProfound Medical Corporation
08/11/202313h45GlobeNewswire Inc.Profound Medical to Participate in the Stifel 2023 Healthcare ConferenceNASDAQ:PROFProfound Medical Corporation
03/11/202313h00GlobeNewswire Inc.Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC SettingNASDAQ:PROFProfound Medical Corporation
02/11/202321h05GlobeNewswire Inc.Profound Medical Announces Third Quarter 2023 Financial ResultsNASDAQ:PROFProfound Medical Corporation
19/10/202322h30GlobeNewswire Inc.Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to FollowNASDAQ:PROFProfound Medical Corporation
10/10/202322h30GlobeNewswire Inc.Profound Medical 2023 Virtual Analyst & Investor Day AgendaNASDAQ:PROFProfound Medical Corporation
25/09/202322h05GlobeNewswire Inc.Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal BoostNASDAQ:PROFProfound Medical Corporation
21/09/202314h00GlobeNewswire Inc.Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13NASDAQ:PROFProfound Medical Corporation
19/09/202322h45GlobeNewswire Inc.Profound Medical to Participate in the 2023 Cantor Global Healthcare ConferenceNASDAQ:PROFProfound Medical Corporation
07/09/202301h23GlobeNewswire Inc.Profound Medical Announces At-the-Market Offering of up to US$30,000,000NASDAQ:PROFProfound Medical Corporation
09/08/202322h05GlobeNewswire Inc.Profound Medical Announces Second Quarter 2023 Financial ResultsNASDAQ:PROFProfound Medical Corporation
02/08/202322h30GlobeNewswire Inc.Profound Medical to Release Second Quarter 2023 Financial Results on August 9 – Conference Call to FollowNASDAQ:PROFProfound Medical Corporation
02/06/202319h40GlobeNewswire Inc.Profound Medical Announces New CPT® Category 1 Codes from the AMA for TULSA to Treat Prostate DiseasesNASDAQ:PROFProfound Medical Corporation
 Showing the most relevant articles for your search:NASDAQ:PROF

Kürzlich von Ihnen besucht

BIT
F17533
Vontobel Financial Produ...
USOTC
SWGAF
Swatch Group AKT (PK)
NASDAQ
PEGIX
PIMCO ESG Income Fund In...
COIN
XREUSD
NASDAQI
CRSPLCGT
CRSP US Large Cap Growth...
BIT
F18109
Vontobel Financial Produ...
ASX
XRF
XRF Scientific
BIT
UC84GP
Unicredit Bank
COIN
ICEETH
IceToken
BOV
CMIGF98
CMIGF98 Ex:7,24
LBNK
XBOTUSDT
XBOT
NASDAQ
DUNEW
Dune Acquisition
NASDAQ
GWAC
Good Works Acquisition
COIN
JBYUSD
NYSE
BIPI
BIP Bermuda Holdings I
BIT
F11482
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten